Robin Everts graduated with an MSc. in Animal Sciences from Wageningen Agricultural University, The Netherlands in 1995 and received a PhD from the Department of Veterinary Medicine, Universiteit Utrecht, The Netherlands in 2000. He performed research in embryo/fetal functional genomics at the University of Illinois at Urbana-Champaign (2000-2007).From 2007 - 2014 he worked at Sequenom Bioschiences, Inc in various roles.In 2014 he joined Agena Bioscience, Inc., San Diego, CA, where he is currently employed as Staff Scientist - Global Pharmacogenetics & CLincal Genetics in the Department of Scientific Affairs.At Sequenom and Agena Bioscience, he was responsible for all the Pharmacogenetics assay development. In his current role he is charged to take Agena Bioscience's Pharmacogenetics & Clinical solution global. At the moment anything COVID-19 takes precedence.In 2023 he joined Etalon Dx as Head of Research & Laboratory Operations.He is the (co-) author of 48 peer-reviewed papers.Specialties: SNP, genotyping, assay development, pharmacogenomics, ADME, CYP450, CNV, CNV assay development, copy number variation, CFTR, HPV, animal genomics, cancer mutation screening, OncoCarta, microarray gene expression analysis, methylation, bioinformatics, Perl, R
Listed skills include Genomics, Genetics, Assay Development, Life Sciences, and 27 others.
